Influence of Access, Anticoagulant, and Bleeding Definition on Outcomes of Primary Percutaneous Coronary Intervention: Early Experience of an US Academic Center - Wikidata - wikimedia - TriplyDB

Influence of Access, Anticoagulant, and Bleeding Definition on Outcomes of Primary Percutaneous Coronary Intervention: Early Experience of an US Academic Center

Influence of Access, Anticoagulant, and Bleeding Definition on Outcomes of Primary Percutaneous Coronary Intervention: Early Experience of an US Academic Center

http://www.wikidata.org/entity/Q35141545

about

Influence of Access, Anticoagulant, and Bleeding Definition on Outcomes of Primary Percutaneous Coronary Intervention: Early Experience of an US Academic Center

http://www.wikidata.org/entity/Q35141545

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Influence of Access, Anticoagu ...... ience of an US Academic Center

@ast

Influence of Access, Anticoagu ...... ience of an US Academic Center

@en

type

label

Influence of Access, Anticoagu ...... ience of an US Academic Center

@ast

Influence of Access, Anticoagu ...... ience of an US Academic Center

@en

prefLabel

Influence of Access, Anticoagu ...... ience of an US Academic Center

@ast

Influence of Access, Anticoagu ...... ience of an US Academic Center

@en

P1433

Q35141545-507231AF-F6A0-4956-9C50-2B404A8292C9

P1476

Q35141545-2A2D2FD9-232B-4CF9-B937-91B84AEAEE1C

P2093

Q35141545-251409A7-B6E9-43F5-8A54-9CA87A5151ED

Q35141545-3C6DB40B-5763-432D-B1F6-192A8112750A

Q35141545-4E705F38-ACEF-4E4D-94C8-586F0522CE39

Q35141545-8461FD18-7FCF-413D-8F88-6C35FE1B1BDE

Q35141545-858AA6E5-6A81-44DF-8EEC-1A92363091AE

Q35141545-963A1949-43FD-4BD1-A489-5F61A93B850B

Q35141545-F617BFAA-92DA-458A-9316-29ECFC997F64

P2860

Q35141545-04CD09A8-33E5-427C-950B-25DA5EE573BE

Q35141545-06A4DF82-2A26-4906-9961-D6856F841295

Q35141545-18155DB0-27E0-4B3B-AAB7-06E62BA28BDE

Q35141545-242D4F9F-548B-47AE-B590-5D09EB537B3F

Q35141545-2FEF00BB-34F9-4DE6-B01D-40DB0BCBE11D

Q35141545-3C8B7C14-CEEA-4A6D-AC53-71CFE2F1A74F

Q35141545-59BBC40C-E3CE-44F5-AE58-16FB783393CC

Q35141545-74FDD470-B14C-4DFA-AE1C-00BE682E1869

Q35141545-8EFE769C-D3DD-44DC-8172-889AB8438D07

Q35141545-9B250091-6BA1-483B-8F92-D98C1AAB79BF

P304

Q35141545-276E20F4-C3DF-4371-B6F0-D8DA422E2894

P31

Q35141545-09580C86-4608-4E57-82DF-926AFC286E66

P356

Q35141545-88BF416A-245C-4FDE-8A6C-57BA42B965D8

P433

Q35141545-56AD9734-C72C-434E-9078-E89EA9044BA0

P478

Q35141545-A10E7894-948F-4EEF-8D0F-6205D9F28159

P577

Q35141545-C2FD6569-CC62-4D1E-A9E3-773F53EC6601

P5875

Q35141545-015DB8E7-2702-40BD-B035-FCCB2EDBCD4E

P698

Q35141545-13400EB7-B5B8-4725-9BA3-F3EC549C0819

P921

Q35141545-2EDBBB44-FF38-4887-98A3-E8051BD2C728

P932

Q35141545-5CD3A5C3-AABB-41F6-BA30-6F1217379B40

P356

P1433

The International journal of angiology : official publication of the International College of Angiology, Inc

P1476

Influence of Access, Anticoagu ...... ience of an US Academic Center

@en

P2093

K Fujise

http://www.w3.org/2001/XMLSchema#string

M K Bheemarasetti

http://www.w3.org/2001/XMLSchema#string

S A Gilani

http://www.w3.org/2001/XMLSchema#string

S Chithri

http://www.w3.org/2001/XMLSchema#string

S Shawar

http://www.w3.org/2001/XMLSchema#string

U M Rangasetty

http://www.w3.org/2001/XMLSchema#string

W I Khalife

http://www.w3.org/2001/XMLSchema#string

P2860

Bivalirudin during primary PCI in acute myocardial infarction

Comparison of bivalirudin and radial access across a spectrum of preprocedural risk of bleeding in percutaneous coronary intervention: analysis from the national cardiovascular data registry.

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

Clinical end points in coronary stent trials: a case for standardized definitions.

Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.

Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.

Observations on blood viscosity changes after acute myocardial infarction.

P304

11-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0034-1394158

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273700828

http://www.w3.org/2001/XMLSchema#string

P698

25780323

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

4347827

http://www.w3.org/2001/XMLSchema#string